Zhengye Biotechnology Holding Limited (ZYBT) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 380.76M |
| Enterprise Value | 405.51M |
| P/E Ratio | -36.36 |
| PEG Ratio | -0.36 |
| Price/Sales Ratio | 32.08 |
| Price/Book Ratio | 10.28 |
| Enterprise/Revenue | 32.39 |
| Enterprise/EBITDA | -62.61 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | -0.89 |
| Operating Margin | -0.77 |
AD
Management Effectiveness
| Return On Assets | -0.16 |
| Return On Equity | -0.27 |
Income Statement
| Revenue | 116.36M |
| Revenue/Share | 1.69 |
| Gross Profit | 23.87M |
| EBITDA | -42.52M |
| Net Income | -69.78M |
| Diluted EPS | -1.4 |
Balance Sheet
| Total Cash | 51.89M |
| Total Cash/Share | 1.09 |
| Total Debt | 75.08M |
| Total Debt/Equity | 0.3 |
| Current Ratio | 1.14 |
| Book Value Per Share | 6.47 |
Price History
| 52-Week Change | 40.77 |
| 52-Week High | 13.08 |
| 52-Week Low | 0.62 |
| Moving Average 50 Days | 0.82 |
| Moving Average 200 Days | 1.33 |
Statistics
| Average Volume | 100,924 |
| Shares Outstanding | 47.39M |
| % Held by Institutions | 0.26 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
